Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Cash Flow from Operations

Aerie Pharmaceuticals Cash Flow from Operations Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Cash Flow from Operations from 2012 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Aerie Pharmaceuticals Cash Flow from Operations for the quarter ending June 06, 2020 was $-23m a -67.01% increase of 15m year over year
  • Aerie Pharmaceuticals Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-130m a -19.08% increase of 25m year over year
  • Aerie Pharmaceuticals Annual Cash Flow from Operations for 2019 was $-150m a -1.43% increase of 2m from 2018
  • Aerie Pharmaceuticals Annual Cash Flow from Operations for 2018 was $-153m a 38.91% decrease of -59m from 2017
  • Aerie Pharmaceuticals Annual Cash Flow from Operations for 2017 was $-93m a 14.35% decrease of -13m from 2016
Other Cash Flow Metrics:
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-29m a -53.21% increase of 16m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Cash Flow from Operations Data

06/2020$-23m
03/2020$-42m
12/2019$-27m
09/2019$-38m
06/2019$-36m
03/2019$-49m
12/2018$-32m
09/2018$-43m
06/2018$-37m
03/2018$-41m

Annual AERI Cash Flow from Operations Data

2019$-150m
2018$-153m
2017$-93m
2016$-80m
2015$-56m
2014$-34m
2013$-16m
2012$-15m
2011$-12m